Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vitamin B12 deficiency anemia in an exclusively breastfed infant born to an ileum-resected mother.
Tamura A, Nino N, Yamamoto N, Naito A, Matsubara K, Nakatani N, Ichikawa T, Nakamura S, Saito A, Kozaki A, Kishimoto K, Ishida T, Shigematsu Y, Hasegawa D, Kosaka Y. Tamura A, et al. Among authors: nakatani n. Pediatr Neonatol. 2019 Oct;60(5):579-580. doi: 10.1016/j.pedneo.2019.06.002. Epub 2019 Jun 11. Pediatr Neonatol. 2019. PMID: 31266738 Free article. No abstract available.
Minimal residual disease in high-risk neuroblastoma shows a dynamic and disease burden-dependent correlation between bone marrow and peripheral blood.
Lin KS, Uemura S, Thwin KKM, Nakatani N, Ishida T, Yamamoto N, Tamura A, Saito A, Mori T, Hasegawa D, Kosaka Y, Nino N, Nagano C, Takafuji S, Iijima K, Nishimura N. Lin KS, et al. Among authors: nakatani n. Transl Oncol. 2021 Aug;14(8):101019. doi: 10.1016/j.tranon.2021.101019. Epub 2021 May 14. Transl Oncol. 2021. PMID: 33993097 Free PMC article.
Limited correlation between tumor markers and minimal residual disease detected by seven neuroblastoma-associated mRNAs in high-risk neuroblastoma patients.
Uemura S, Lin KS, Mon Thwin KK, Nakatani N, Ishida T, Yamamoto N, Tamura A, Saito A, Mori T, Hasegawa D, Kosaka Y, Nino N, Nagano C, Takafuji S, Iijima K, Nishimura N. Uemura S, et al. Among authors: nakatani n. Mol Clin Oncol. 2021 Jul;15(1):137. doi: 10.3892/mco.2021.2299. Epub 2021 May 19. Mol Clin Oncol. 2021. PMID: 34055352 Free PMC article.
Minimal residual disease detected by droplet digital PCR in peripheral blood stem cell grafts has a prognostic impact on high-risk neuroblastoma patients.
Nino N, Ishida T, Nakatani N, Lin KS, Win KHN, Mon CY, Nishimura A, Inoue S, Tamura A, Yamamoto N, Uemura S, Saito A, Mori T, Hasegawa D, Kosaka Y, Nozu K, Nishimura N. Nino N, et al. Among authors: nakatani n. Heliyon. 2022 Oct 8;8(10):e10978. doi: 10.1016/j.heliyon.2022.e10978. eCollection 2022 Oct. Heliyon. 2022. PMID: 36276741 Free PMC article.
Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high‑risk neuroblastoma: A case report.
Inoue S, Win KHN, Mon CY, Fujikawa T, Hyodo S, Uemura S, Ishida T, Mori T, Hasegawa D, Kosaka Y, Nishimura A, Nakatani N, Nino N, Tamura A, Yamamoto N, Nozu K, Nishimura N. Inoue S, et al. Among authors: nakatani n. Oncol Lett. 2023 Jul 14;26(3):369. doi: 10.3892/ol.2023.13955. eCollection 2023 Sep. Oncol Lett. 2023. PMID: 37559575 Free PMC article.
170 results